Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway
Abstract
Parkinson's disease (PD) is characterized by a progressive and selective loss of dopaminergic (DA) neurons in the substantia nigra (SN). Although the etiology of PD remains unclear, neuroinflammation has been implicated in the development of PD. Running exercise (Ex) promotes neuronal survival and facilitates the recovery of brain functions after injury. Therefore, we hypothesize that Ex protects the DA neurons against inflammation-induced injury in the SN. An intraperitoneal lipopolysaccharide (LPS, 1 mg/kg) injection induced microglia activation in the SN within hours, followed by a reduction in the number of DA neurons. LPS reduced the level of dopamine in the striatum and impaired the performance of motor coordination. Furthermore, the levels of the brain-derived neurotrophic factor (BDNF) were reduced in the SN by the LPS treatment. Four weeks of Ex before LPS treatment completely prevented the LPS-induced loss of DA neurons, reduction of dopamine levels and dysfunction of motor movement. Ex did not change the LPS-induced status of microglia activation or the levels of cytokines/chemokines, but restored the levels of LPS-reduced BDNF-TrkB signaling molecules. Blocking the action of BDNF, through its receptor TrkB antagonist, abolished the Ex-induced protection against LPS-induced DA neuron loss. Intrastriatal perfusion of BDNF alone was sufficient to counteract the LPS-induced DA neuron loss. Altogether, our results show that Ex protects DA neurons against inflammation-induced insults. The neuroprotective effects of Ex are not due to the modulation of inflammation status, but rather to the activation of the BDNF-TrkB signaling pathway.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BDNF upregulation due to exercise was observed in midbrain, substantia nigra, striatum, hippocampus, and cortex.
“BDNF upregulation was observed in midbrain [125], SN [126,128,129], ST [127,129,131,133], hippocampus [133], and cortex [132,133].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [129]
Exercise increased TrkB content in substantia nigra.
“In another study, it was shown that exercise increased TrkB content in SN [129]; however, in yet another study, TrkB content was significantly decreased in ST even below the level in the sedentary PD mice [131].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [129]
Long-term endurance training increases TH expression in structures involved in extrapyramidal movement regulation, i.e., the ST and midbrain.
“Animal studies have shown that long-term endurance training increased both TrkB receptor and TH expression in structures involved in extrapyramidal movement regulation, i.e., in the ST and midbrain [128,129,179,183,184,185].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [129]
Long-term endurance training increases TrkB receptor expression in structures involved in extrapyramidal movement regulation, i.e., the ST and midbrain.
“Animal studies have shown that long-term endurance training increased both TrkB receptor and TH expression in structures involved in extrapyramidal movement regulation, i.e., in the ST and midbrain [128,129,179,183,184,185].”
From BDNF as a Promising Therapeutic Agent in Parkinson’s Disease (2020) · cites this paper as [129]
Studies in the MPTP mouse model have demonstrated that intensive exercise can restore aspects of glutamate receptor expression, including the AMPA receptor subtype.
“Studies in the MPTP mouse model have demonstrated that intensive exercise can restore aspects of glutamate receptor expression, including the glutamate receptor subtype AMPA 85.”
From Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease (2013) · cites this paper as [85]
Cites
1 retracted
Chae, C.-H., Jung, S.-L., An, S. H., Park, B. Y., Wang, S. W., Cho, I., Cho, J. Y., & Kim, H. T. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.09.075 · Cited by 51 · see citing works
RetractedMicroglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works
GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons
Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206 · see citing works
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works
Exercise: a behavioral intervention to enhance brain health and plasticity
Cotman, C. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02143-4 · Cited by 2,739 · see citing works
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · see citing works
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557 · see citing works
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Hyman, C., Hofer, M., Barde, Y., Juhasz, M., Yancopoulos, G. D., Squinto, S. P., & Lindsay, R. M. (1991) · Nature · doi:10.1038/350230a0 · Cited by 1,494 · see citing works
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079 · see citing works
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986 · see citing works
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 918 · see citing works
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · see citing works
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855 · see citing works
Circulating Insulin-Like Growth Factor I Mediates Effects of Exercise on the Brain
Carro, E., Nuñez, A., Busiguina, S., & Torres-Aleman, I. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02926.2000 · Cited by 762 · see citing works
Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity
Gómez-Pinilla, F., Ying, Z., Roy, R. R., Molteni, R., & Edgerton, V. R. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00152.2002 · Cited by 724 · see citing works
Gao, H., Jiang, J., Wilson, B. C., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 690 · see citing works
Structure and function of lipopolysaccharides
Erridge, C., Bennett‐Guerrero, E., & Poxton, I. R. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01604-0 · Cited by 682 · see citing works
D'Mello, C., Le, T., & Swain, M. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3567-08.2009 · Cited by 675 · see citing works
Structure and function of phosphoinositide 3-kinases
Wymann, M. P., & Pirola, L. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00139-8 · Cited by 662 · see citing works
Beck, K. D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R. A., Rosenthal, A., & Hefti, F. F. (1995) · Nature · doi:10.1038/373339a0 · Cited by 654 · see citing works
Exercise and the brain: something to chew on
van Praag, H. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.007 · Cited by 599 · see citing works
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595 · see citing works
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, É. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 591 · see citing works
Invited Article: Nervous system pathology in sporadic Parkinson disease
Braak, H., & Tredici, K. D. (2008) · Neurology · doi:10.1212/01.wnl.0000312279.49272.9f · Cited by 536 · see citing works
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503 · see citing works
Tapley, P. M., Lamballe, F., & Barbacid, M. (1992) · PubMed · Cited by 497 · see citing works
Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H., Hong, J., Zhang, W., & Liu, B. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439 · see citing works
Neuroinflammation and Oxidation/Nitration of α-Synuclein Linked to Dopaminergic Neurodegeneration
Gao, H., Kotzbauer, P. T., Uryu, K., Leight, S., Trojanowski, J. Q., & Lee, V. M. ‐. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0143-07.2008 · Cited by 435 · see citing works
Akt-dependent transformation: there is more to growth than just surviving
Plas, D. R., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209097 · Cited by 427 · see citing works
Tillerson, J. L., Caudle, W. M., Reverón, M. E., & Miller, G. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00096-4 · Cited by 399 · see citing works
Chakravarty, S., & Herkenham, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4268-04.2005 · Cited by 396 · see citing works
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 393 · see citing works
GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo
Kearns, C. M., & Gash, D. M. (1995) · Brain Research · doi:10.1016/0006-8993(94)01366-p · Cited by 379 · see citing works
Absolute requirement of GDNF for adult catecholaminergic neuron survival
Pascual, A., Hidalgo‐Figueroa, M., Piruat, J. I., Pintado, C. O., Gómez-Díaz, R., & López‐Barneo, J. (2008) · Nature Neuroscience · doi:10.1038/nn.2136 · Cited by 332 · see citing works
Petzinger, G. M., Walsh, J. P., Akopian, G., Hogg, E., Abernathy, A., Arevalo, P., Turnquist, P., Vučković, M., Fisher, B. E., Togasaki, D. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1069-07.2007 · Cited by 329 · see citing works
An inflammatory review of Parkinson's disease
Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309 · see citing works
Exercise exerts neuroprotective effects on Parkinson's disease model of rats
Tajiri, N., Yasuhara, T., Shingo, T., Kondo, A., Yuan, W., Kadota, T., Wang, F., Baba, T., Tayra, J. T., Morimoto, T., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2009.10.075 · Cited by 308 · see citing works
The influence of microglia on the pathogenesis of Parkinson's disease
Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296 · see citing works
Schefer, V., & Talan, M. I. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(95)02032-2 · Cited by 278 · see citing works
Griesbach, G. S., Hovda, D. A., & Gómez‐Pinilla, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.045 · Cited by 274 · see citing works
Mattson, M. P., Maudsley, S. R., & Martin, B. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.08.001 · Cited by 266 · see citing works
K‐252 Compounds: Modulators of Neurotrophin Signal Transduction
Knüsel, B., & Hefti, F. F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10085.x · Cited by 242 · see citing works
Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism
Faherty, C. J., Shepherd, K. R., Herasimtschuk, A., & Smeyne, R. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.08.008 · Cited by 241 · see citing works
Castaño, A., Herrera, A. J., Cano, J., & Machado, A. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 239 · see citing works
Liu, Y., Qin, L., Li, G., Zhang, W., An, L., Liu, B., & Hong, J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043166 · Cited by 205 · see citing works
Wu, C.-W. J., Chang, Y.-T., Yu, L., Chen, H., Jen, C. J., Wu, S.-Y., Lo, C., & Kuo, Y. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90775.2008 · Cited by 204 · see citing works
Self-citationSon, J. H., Chun, H. S., JOH, T. H., Cho, S., Conti, B., & Lee, J. W. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00010.1999 · Cited by 195 · see citing works
Herman, T., Giladi, N., & Hausdorff, J. M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-008-0139-z · Cited by 193 · see citing works
Wu, C., Chen, Y., Yu, L., Chen, H., Jen, C. J., Huang, A., Tsai, H., Chang, Y., & Kuo, Y. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04987.x · Cited by 175 · see citing works
Self-citationLiu, B., Jiang, J., Wilson, B. C., Du, L., Yang, S., Wang, J., Wu, G.-C., Cao, X.-D., & Hong, J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38877-9 · Cited by 167 · see citing works
Laflamme, N., Echchannaoui, H., Landmann, R. M., & Rivest, S. (2003) · European Journal of Immunology · doi:10.1002/eji.200323821 · Cited by 160 · see citing works
Devi, S. A., & Kiran, T. R. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00112-x · Cited by 154 · see citing works
Baquet, Z. C., Williams, D., Brody, J., & Smeyne, R. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.031 · Cited by 149 · see citing works
Yoon, M.-C., Shin, M., Kim, T.-S., Kim, B.-K., Ko, I., Sung, Y.-H., Kim, S., Lee, H., Kim, Y.-P., & Kim, C. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.031 · Cited by 141 · see citing works
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease
Hernán, M. Á., Logroscino, G., & Rodríguez, L. A. G. (2006) · Neurology · doi:10.1212/01.wnl.0000204446.82823.28 · Cited by 137 · see citing works
Brain Repair and Neuroprotection by Serum Insulin-Like Growth Factor I
Carro, E., Trejo, J. L., Núñez, Á., & Torres‐Alemán, I. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:2:153 · Cited by 122 · see citing works
Autoimmune disease and risk for Parkinson disease
Rugbjerg, K., Friis, S., Ritz, B. R., Schernhammer, E. S., Korbo, L., & Olsen, J. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c06635 · Cited by 120 · see citing works
Dopamine Quinones Activate Microglia and Induce a Neurotoxic Gene Expression Profile
Kuhn, D. M., Francescutti‐Verbeem, D. M., & Thomas, D. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.003 · Cited by 111 · see citing works
Gibb, J., Hayley, S. P., Gandhi, R., Poulter, M. O., & Anisman, H. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.12.001 · Cited by 111 · see citing works
Pei, Z., Pang, H., Qian, L., Yang, S., Wang, T., Zhang, W., Wu, X., Dallas, S., Wilson, B., Reece, J. M., et al. (2007) · Glia · doi:10.1002/glia.20545 · Cited by 105 · see citing works
Gobbo, O. L., & O’Mara, S. M. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.09.021 · Cited by 104 · see citing works
Effect of physical exercise on mortality in patients with Parkinson's disease
Kuroda, K., Tatara, K., Takatorige, T., & Shinsho, F. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb08054.x · Cited by 98 · see citing works
Genetic analysis of immunomodulating factors in sporadic Parkinson's disease
Krüger, R., Hardt, C., Tschentscher, F., Jäckel, S., Kuhn, W., Müller, T., Werner, J., Woitalla, D., Berg, D., Kühnl, N., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070078 · Cited by 93 · see citing works
Motor training effects on recovery of function after striatal lesions and striatal grafts
Döbrössy, M. D., & Dunnett, S. B. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00028-1 · Cited by 82 · see citing works
Evidence for and against a Pivotal Role of PI 3-Kinase in a Neuronal Cell Survival Pathway
Williams, E., & Doherty, P. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0750 · Cited by 74 · see citing works
McNeill, T. H., & Koek, L. L. (1990) · Brain Research · doi:10.1016/0006-8993(90)91530-t · Cited by 73 · see citing works
Thomas, D. M., Francescutti, D. M., & Kuhn, D. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4873fje · Cited by 73 · see citing works
Sobreviela, T., Pagcatipunan, M., Kroin, J. S., & Mufson, E. J. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961118)375:3 · Cited by 69 · see citing works
Liu, B., Qin, L., Yang, S., Wilson, B. C., Liu, Y., & Hong, J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29483-0 · Cited by 65 · see citing works
Zhou, J., Bradford, H. F., & STERN, G. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91376-5 · Cited by 62 · see citing works
Effects of Enhanced Striatal Dopamine Turnover In Vivo on Glutathione Oxidation
Loeffler, D. A., DeMaggio, A. J., Juneau, P. L., Havaich, M. K., & LeWitt, P. A. (1994) · Clinical Neuropharmacology · doi:10.1097/00002826-199408000-00009 · Cited by 61 · see citing works
Datta, S. C., & Opp, M. R. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.08.007 · Cited by 60 · see citing works
Benmansour, S., Deltheil, T., Piotrowski, J. P., Nicolas, L., Repérant, C., Gardier, A. M., Frazer, A., & David, D. J. P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.048 · Cited by 52 · see citing works
Chang, Y.-T., Chen, Y., Wu, C.-W. J., Yu, L., Chen, H., Jen, C. J., & Kuo, Y. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.05.014 · Cited by 51 · see citing works
Self-citationMufson, E. J., Kroin, J. S., Liu, Y.-T., Sobreviela, T., Penn, R. D., Miller, J., & Kordower, J. H. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00431-9 · Cited by 47 · see citing works
Studer, L., Spenger, C., Seiler, R. D., Othberg, A. I., Lindvall, O., & Odin, P. (1996) · Experimental Brain Research · doi:10.1007/bf00228106 · Cited by 45 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging
Ahlskog, J. E., Geda, Y. E., Graff-Radford, N. R., & Petersen, R. C. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0252 · Cited by 885 · see citing works
Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease
Petzinger, G. M., Fisher, B. E., McEwen, S., Beeler, J. A., Walsh, J. P., & Jakowec, M. W. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70123-6 · Cited by 798 · see citing works
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504 · see citing works
Does vigorous exercise have a neuroprotective effect in Parkinson disease?
Ahlskog, J. E. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab66 · Cited by 463 · see citing works
Walker, A. K., Budac, D. P., Bisulco, S., Lee, A. W., Smith, R. A., Beenders, B., Kelley, K. W., & Dantzer, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.71 · Cited by 432 · see citing works
Exercise Benefits Brain Function: The Monoamine Connection
Lin, T.-W., & Kuo, Y.-M. (2013) · Brain Sciences · doi:10.3390/brainsci3010039 · Cited by 392 · see citing works
Self-citationStress, depression and Parkinson's disease
Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225 · see citing works
Moylan, S., Eyre, H. A., Maes, M., Baune, B. T., Jacka, F. N., & Berk, M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.003 · Cited by 155 · see citing works
Hirsch, M. A., van Wegen, E. E. H., Newman, M. A., & Heyn, P. C. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0112-1 · Cited by 134 · see citing works
Comparing interval and continuous exercise training regimens on neurotrophic factors in rat brain
Afzalpour, M. E., Chadorneshin, H. T., Foadoddini, M., & Eivari, H. A. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.04.012 · Cited by 131 · see citing works
Real, C. C., Ferreira, A. F. B., Chaves-Kirsten, G. P., Torrão, A. S., Pires, R. S., & Britto, L. R. G. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.060 · Cited by 109 · see citing works
Palasz, E., Niewiadomski, W., Gasiorowska, A., Wysocka, A., Stepniewska, A., & Niewiadomska, G. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01143 · Cited by 95 · see citing works
Neuroprotective Effects of Exercise Treatments after Injury: The Dual Role of Neurotrophic Factors
Cobianchi, S., Arbat-Plana, A., Lopez-Alvarez, V. M., & Navarro, X. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160330105132 · Cited by 94 · see citing works
Differential distribution and activation of microglia in the brain of male C57BL/6J mice
Yang, T.-T., Lin, C., Hsu, C.-T., Wang, T.-F., Ke, F.-Y., & Kuo, Y.-M. (2013) · Brain Structure and Function · doi:10.1007/s00429-012-0446-x · Cited by 92 · see citing works
Self-citationNeurotrophic factors in Parkinson’s disease are regulated by exercise: Evidence-based practice
da Silva, P. G. C., Domingues, D. D., de Carvalho, L. A., Allodi, S., & Correa, C. L. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.02.017 · Cited by 87 · see citing works
Hird, E. J., Slanina-Davies, A., Lewis, G., Hamer, M., & Roiser, J. P. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02922-y · Cited by 79 · see citing works
Cebrián, C., Loike, J. D., & Sulzer, D. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_356 · Cited by 65 · see citing works
Exercise does not protect against MPTP-induced neurotoxicity in BDNF happloinsufficent mice
Gerecke, K. M., Jiao, Y., Pagala, V., & Smeyne, R. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043250 · Cited by 53 · see citing works
Palasz, E., Niewiadomski, W., Gasiorowska, A., Mietelska-Porowska, A., & Niewiadomska, G. (2019) · Neural Plasticity · doi:10.1155/2019/8215017 · Cited by 39 · see citing works
Chen, M., Huang, T., Kuo, Y., Yu, L., Chen, H., & Jen, C. J. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.241125 · Cited by 37 · see citing works
Self-citation
- Authors
- Wu, S.-Y., Wang, T.-F., Yu, L., Jen, C. J., Chuang, J.-I., Wu, F.-S., Wu, C.-W., & Kuo, Y.-M.
- Affiliations
- National Cheng Kung University (TW)
- Venue
- Brain Behavior and Immunity
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 25
- Issue
- 1
- Pages
- 135-146
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W1984965817
- Cited by
- 206
- References
- 77
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 14 · 2023: 6 · 2022: 13 · 2021: 10 · 2020: 14 · 2019: 16 · 2018: 20 · 2017: 10 · 2016: 11 · 2015: 16 · 2014: 16 · 2013: 13 · 2012: 15
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cheng Kung University
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Keywords
- running, Parkinson's disease, substantia nigra, dopaminergic neurons, neuroinflammation, lipopolysaccharide, microglial activation, brain-derived neurotrophic factor, TrkB signaling, neuroprotection, dopamine, motor coordination, striatum
- MeSH terms
- Animals, Carbazoles, Cell Count, Cell Survival, Corpus Striatum, Dopamine, Immunohistochemistry, Inflammation, Injections, Intraventricular, Male, Mice, Inbred C57BL, Motor Activity, Nerve Degeneration, Neurons, Physical Conditioning, Animal, Psychomotor Performance, Running, Substantia Nigra, Signal Transduction, Cytokines, Microglia, Chemokines, Brain-Derived Neurotrophic Factor, Indole Alkaloids, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review